Research Article

Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice

Table 2

Results of multiple logistic regression.

QT prolongationSevere QT prolongation
VariablesOR95% CIp-valueOR95% CIp-value

Azithromycin1.395(1.227-1.586)<.00011.433(1.127-1.822)0.003
Amoxicillin1.056(0.971-1.147)0.2040.875(0.703-1.089)0.231
Male (ref. female)1.108(1.088-1.129)<.00010.854(0.817-0.892)<.0001
Age (Mean/SD)1.023(1.022-1.023)<.00011.028(1.026-1.029)<.0001
Potassium (mEq/l)0.679(0.666-0.691)<.00010.537(0.515-0.559)<.0001
Calcium (mg/dl)0.645(0.636-0.654)<.00010.541(0.525-0.557)<.0001
Antiarrhythmic drugs3.341(3.111-3.589)<.00015.326(4.807-5.900)<.0001
Antianginal drugs1.331(0.458-3.867)0.599
Anticholinergic1.132(0.935-1.370)0.2020.919(0.585-1.441)0.712
Antimalarials1.080(0.933-1.251)0.3000.812(0.550-1.198)0.294
Antifungals1.073(0.916-1.258)0.3841.126(0.816-1.552)0.471
Fluoroquinolone antibiotics1.198(1.144-1.255)<.00011.195(1.083-1.318)0.000
HIV antiretrovirals1.048(0.460-2.385)0.912
Macrolide antibiotics1.599(1.507-1.696)<.00011.566(1.393-1.761)<.0001
Antihistamines1.483(1.304-1.687)<.00011.193(0.901-1.580)0.219
Antineoplastic drugs0.580(0.527-0.638)<.00010.407(0.298-0.557)<.0001
Anesthetic/sedative1.151(1.093-1.212)<.00011.169(1.039-1.314)0.009
Opioids1.124(0.768-1.645)0.5491.016(0.373-2.764)0.976
Bronchodilators (beta-agonists)1.346(1.229-1.473)<.00011.093(0.887-1.347)0.404
Antidiarrheals1.091(0.734-1.623)0.6661.035(0.369-2.901)0.948
Antiemetics0.963(0.870-1.066)0.4680.881(0.696-1.115)0.291
Gastrointestinal promotility1.777(1.729-1.827)<.00011.583(1.492-1.681)<.0001
GnRH1.581(1.067-2.343)0.0230.612(0.150-2.496)0.493
Neurologic drugs1.110(0.895-1.376)0.3431.268(0.865-1.861)0.224
Antipsychotics1.325(1.259-1.395)<.00011.150(1.028-1.286)0.014
Tricyclic and tetracyclic antidepressants0.978(0.898-1.065)0.6120.870(0.699-1.083)0.213
Selective serotonin reuptake inhibitors1.119(1.005-1.246)0.0411.117(0.882-1.415)0.358
Vasodilator drugs1.399(1.281-1.528)<.00011.379(1.157-1.643)0.000
Myocardial infarction1.306(1.242-1.374)<.00011.387(1.257-1.530)<.0001
Congestive heart failure2.526(2.403-2.654)<.00013.547(3.279-3.837)<.0001
Ischemic stroke1.429(1.368-1.493)<.00011.394(1.274-1.525)<.0001
Hemorrhagic stroke2.276(2.123-2.441)<.00013.143(2.797-3.531)<.0001
Diabetes mellitus1.167(1.133-1.201)<.00011.016(0.950-1.086)0.643
Hypothyroidism0.929(0.842-1.025)0.1401.033(0.834-1.280)0.767
Renal disease3.119(2.993-3.250)<.00013.320(3.077-3.582)<.0001
AIDS/HIV1.434(0.893-2.301)0.1351.112(0.273-4.535)0.882
Alcohol abuse2.108(1.938-2.293)<.00011.912(1.645-2.221)<.0001
Drug abuse3.009(2.538-3.567)<.00014.356(3.275-5.794)<.0001
Liver disease2.301(2.166-2.444)<.00012.349(2.097-2.631)<.0001
Severe liver disease2.233(1.991-2.505)<.00011.975(1.651-2.362)<.0001
Year of QTc diagnosis (ref. year 1995–2000)
 2001–20050.965(0.910-1.023)0.2291.043(0.922-1.179)0.507
 2006–20101.466(1.384-1.552)<.00011.027(0.910-1.161)0.662
 2011–20151.812(1.712-1.918)<.00011.149(1.018-1.297)0.025

GnRH: Gonadotropin-releasing hormone agonists and antagonists; AIDS: acquired immunodeficiency syndrome; HIV: human immunodeficiency virus; SD: standard deviation; OR: odds ratio; CI: confidence interval; QTc: